UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 13, 2015
GENSPERA, INC.
(Exact name of registrant as specified in Charter)
| Delaware | 0001421204 | 20-0438951 |
(State or other jurisdiction of incorporation or organization) | (Commission File No.) | (IRS Employee Identification No.) |
2511 N Loop 1604 W, Suite 204
San Antonio, TX 78258
(Address of Principal Executive Offices)
210-479-8112
(Issuer Telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 8.01 | Other Events. |
On May 13, 2015, GenSpera, Inc. (the “Company”) issued a press release announcing the successful completion of the first stage of its ongoing Phase II study of mipsagargin in glioblastoma, as well as the continuation of enrollment for an expansion phase of the trial. A copy of the press release is attached to this report as Exhibit 99.01.
| Item 9.01 | Financial Statements and Exhibits. |
Exhibit No. |
Description | |
| 99.01 | Press Release dated May 13, 2015. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 13, 2015
| GenSpera, Inc. | |||
| By: | /s/ Craig Dionne | ||
| Craig Dionne | |||
| Chief Executive Officer | |||
INDEX OF EXHIBITS
Exhibit No. |
Description | |
| 99.01 | Press Release dated May 13, 2015. |
